Showing 1181-1190 of 4902 results for "".
Science of Skincare Summit 2024: Ethical Relationships with Industry
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-ethical-relationships-with-industry/29455/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Nada Elbuluk, MD, a dermatologist at the University of Southern California specializing in pigmentary disorders and skin of color, about building relationships with industry that maintain proper independence and compliance with pScience of Skincare Summit 2024:Presentation of Disease in Patients with Skin of Color
https://practicaldermatology.com/conferences/science-skincare-summit-2024/science-of-skincare-summit-2024-presentation-of-disease-in-patients-with-skin-of-color/29456/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Nada Elbuluk, MD, a dermatologist at the University of Southern California specializing in pigmentary disorders and skin of color, about some of the challenges of diagnosing disease such as erythema in patients with skin of colorImplications of the Overlap Between CSU and Atopic Dermatitis
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/implications-of-the-overlap-between-csu-and-atopic-dermatitis/50850/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, is joined by Northwestern University Feinberg School of Medicine Associate Professor Walter Liszewski, MD, to discuss the article “Co-existence of chronic spontaneous urticaria and atopic dermatitis: clinical and immunological perspecWhy Assessing Vitiligo Activity is Critical for Limiting Spread
https://practicaldermatology.com/conferences/maui-derm-2024/why-assessing-vitiligo-activity-is-critical-for-limiting-spread/20248/Chief Medical Editor Neal Bhatia, MD talks with “Mr. Vitiligo Himself,” John E. Harris, MD, PhD about the importance of determining whether vitiligo patients are active or stable in order to “shut off” spreading as soon as possible.DermWire TV Extra: How ILDS Helps Dermatology Go Global
https://practicaldermatology.com/videos/dermwire-tv/dermwire-tv-extra-how-ilds-helps-dermatology-go-global/26912/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, talks with Henry Lim, MD, president of the International League of Dermatology Societies (ILDS), to discuss international developments in research and therapeutics, how ILDS helps enhance dermatologists' interactions with the specialty worlPrurigo Nodularis, Chronic Itch, and Lymphoma Risk
https://practicaldermatology.com/programs/practical-dermatology-type-ii-inflammation-journal-club/prurigo-nodularis-chronic-itch-and-lymphoma-risk/50965/Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, and Lawrence Green, MD, FAAD, examine the link between prurigo nodularis, chronic pruritus, Type 2 inflammation, and lymphoma risk, with a focus on evaluating the underlying causes of persistent itch.Wishful Thinking: Looking to the Year Ahead
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/wishful-thinking-looking-to-the-year-ahead/23435/Cosmetic Surgery Forum faculty share resolutions for 2021.2015 Cosmetic Surgery Forum: Jeanine Downie, MD
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/2015-cosmetic-surgery-forum-jeanine-downie-md/18264/Advocacy and Research
https://practicaldermatology.com/podcasts/practical-dermatology-podcasts/advocacy-and-research/36479/The latest news and updates, plus Harrison Nguyen, MD, MBA, MPH, FAAD, discusses addressing barriers to maximizing biologics for psoriasis, and Mark Lebwohl, MD, FAAD, joins Practical Dermatology Chief Medical Editor Neal Bhatia, MD, FAAD, to talk about some of the latest research he has been involvAre Sunscreens and Cosmetics Really Safe?
https://practicaldermatology.com/topics/skin-cancer-photoprotection/are-sunscreens-and-cosmetics-really-safe/23558/There is basis for some of the concern around skincare ingredients, but dermatologists have the knowledge and expertise to guide patients to products that are safe.